Early access for innovative oncology medicines: a different story in each nation

As innovative oncology medicines are rapidly developed, there is increasing pressure on payers to offer patients timely access to life-saving therapies. The uncertainty surrounding these therapies when phase III clinical trials are pending has necessitated new, adapted pathways to market access, wit...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of medical economics 2023-12, Vol.26 (1), p.944-953
Hauptverfasser:	Cowling, Tara, Nayakarathna, Ransi, Wills, Allison L., Tankala, Dipti, Paul Roc, Nancy, Barakat, Stephane
Format:	Artikel
Sprache:	eng
Schlagworte:	early access HTA Innovative managed access market access oncology RWE
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!